Mereo BioPharma Group plc

Director's Dealing • Jul 19, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1573G

Mereo BioPharma Group plc

19 July 2019

Mereo BioPharma Group plc

("Mereo" or the "Company")

Notification of Director Dealing

London, July 19, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on July 17, 2019, Denise Scots-Knight, Chief Executive Officer of Mereo, purchased 2000 Ordinary Shares at a price of GBP0.45 and 2000 American Depositary Shares (ADSs) at a price of USD2.59 per share. On July 18, 2019, Denise purchased 8000 Ordinary Shares at a price of GBP0.45 and 2000 ADSs at a price of USD2.55 per share.

The below announcement and notification is made in accordance with the EU Market Abuse Regulation.  The form required under the EU Market Abuse Regulation follows.

1

Details of the person discharging managerial responsibilities

a)

Name

Denise Scots-Knight

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mereo BioPharma Group plc

b)

LEI

213800U8JQHIJOS5AS09

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

MEREO BIOPHARMA GROUP PLC ORDINARY SHARES

b)

Nature of the transaction

PURCHASE

c)

Price(s) and volume(s)

Price(s)	Volume(s)
GBP0.45	2000

d)

Aggregated information:  volume, Price

Aggregated volume: 2000

Aggregated price: GBP0.45

e)

Date of the transaction

2019-07-17

f)

Place of the transaction

AIMX

1

Details of the person discharging managerial responsibilities

a)

Name

Denise Scots-Knight

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mereo BioPharma Group plc

b)

LEI

213800U8JQHIJOS5AS09

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs)

b)

Nature of the transaction

PURCHASE of ADSs

c)

Price(s) and volume(s)

Price(s)	Volume(s)
USD2.59	2000

d)

Aggregated information:  volume, Price

Aggregated volume: 2000  

Aggregated price: GBP2.59

e)

Date of the transaction

2019-7-17

f)

Place of the transaction

XNMS

1

Details of the person discharging managerial responsibilities

a)

Name

Denise Scots-Knight

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mereo BioPharma Group plc

b)

LEI

213800U8JQHIJOS5AS09

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

MEREO BIOPHARMA GROUP PLC ORDINARY SHARES

b)

Nature of the transaction

PURCHASE

c)

Price(s) and volume(s)

Price(s)	Volume(s)
GBP0.45	8000

d)

Aggregated information:  volume, Price

Aggregated volume: 8000 

Aggregated price: GBP0.45

e)

Date of the transaction

2019-07-18

f)

Place of the transaction

AIMX

1

Details of the person discharging managerial responsibilities

a)

Name

Denise Scots-Knight

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mereo BioPharma Group plc

b)

LEI

213800U8JQHIJOS5AS09

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs)

b)

Nature of the transaction

PURCHASE of ADSs

c)

Price(s) and volume(s)

Price(s)	Volume(s)
USD2.55	2000

d)

Aggregated information:  volume, Price

Aggregated volume: 2000 

Aggregated price: GBP2.55

e)

Date of the transaction

2019-7-18

f)

Place of the transaction

XNMS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHLKLFFKDFFBBV